Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells

BACKGROUND: Malignant melanoma in dogs is considered to be largely resistant to conventional chemotherapy, although responses to carboplatin have been documented. Invasion and early metastasis are common features of certain melanoma subtypes that contribute to tumour progression despite aggressive l...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernard, Sarah, Poon, Andrew C., Tam, Peyton M., Mutsaers, Anthony J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665592/
https://www.ncbi.nlm.nih.gov/pubmed/34895222
http://dx.doi.org/10.1186/s12917-021-03089-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665592/
https://www.ncbi.nlm.nih.gov/pubmed/34895222
http://dx.doi.org/10.1186/s12917-021-03089-0

Ejemplares similares